Related Experiment Video
Updated: Oct 11, 2025

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
SIRT1-FOXOs activity regulates diabetic complications
Manjiri P Jalgaonkar1, Urvi M Parmar1, Yogesh A Kulkarni2
1SVKM's Dr Bhanuben Nanavati College of Pharmacy, Vile Parle (W), Mumbai 400056, India.
The interaction between SIRT1 and FOXOs may help treat diabetic complications. This crosstalk highlights potential therapeutic targets for managing conditions like nephropathy and retinopathy.
Area of Science:
- Biochemistry
- Molecular Biology
- Endocrinology
Background:
- Diabetes prevalence is rising, leading to microvascular and macrovascular complications.
- Hyperglycemia, hyperinsulinemia, and oxidative stress drive diabetic complications through pathways like the polyol pathway and AGE production.
- Sirtuins, specifically SIRT1, are NAD+-dependent histone deacetylases with roles in aging and cellular regulation.
Purpose of the Study:
- To explore the interaction between SIRT1 and FOXOs (forkhead box proteins) in the context of diabetic complications.
- To elucidate the underlying mechanisms of SIRT1-FOXO crosstalk in alleviating diabetic complications.
- To identify SIRT1 and FOXOs as potential therapeutic targets for diabetic complications.
Main Methods:
- Literature review focusing on the molecular mechanisms of SIRT1 and FOXO function.
- Analysis of studies investigating the interplay between SIRT1 and FOXOs, particularly FOXO1 and FOXO3.
- Examination of evidence linking SIRT1-FOXO pathways to the pathogenesis and potential treatment of diabetic complications.
Main Results:
- SIRT1 regulates FOXOs' activity, influencing cellular processes like metabolism and DNA repair.
- Recent findings suggest a reciprocal regulation, where FOXOs also govern SIRT1 activity, indicating a crosstalk.
- This SIRT1-FOXO interaction is implicated in controlling and mitigating diabetic complications.
Conclusions:
- The crosstalk between SIRT1 and FOXOs plays a crucial role in managing diabetic complications.
- Targeting the SIRT1-FOXO pathway offers a promising therapeutic strategy for diabetic complications.
- Further research into this interaction could lead to novel treatments for conditions such as nephropathy, retinopathy, and cardiomyopathy.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
PI3K/mTOR/AKT Signaling Pathway
Insulin: The Receptor and Signaling Pathways
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

